Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernd Meibohm

Showing results (51-60 of 171) with videos related to

Pageof 18
Sort By:
Plos One|February 24, 2017
Alterations in cellular pharmacokinetics and pharmacodynamics of elvitegravir in response to ethanol exposure in HIV-1 infected monocytic (U1) cellsNarasimha M Midde, Namita Sinha, Pradeep B Lukka, et al.
Clinical Pharmacology in Drug Development|February 27, 2026
Single-Dose Pharmacokinetic Assessment of TNX-102 SL (Cyclobenzaprine HCl Sublingual Tablets): Results From Randomized, Open-Label Studies in Healthy VolunteersBruce L Daugherty, Bernd Meibohm, Gregory M Sullivan, et al.
Pharmacology Research & Perspectives|July 22, 2015
Preclinical evaluation of SMM-189, a cannabinoid receptor 2-specific inverse agonistChaela Presley, Ammaar Abidi, Satyendra Suryawanshi, et al.
The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG|October 16, 2024
Impact of Age and Concurrent Antiseizure Medication Use on Lacosamide Dose to Concentration Ratio and Dosing in Pediatric PatientsMegan Woods, Stephanie J Phelps, Michael L Christensen, et al.
Tuberculosis (Edinburgh, Scotland)|September 15, 2009
A simple in vitro PK/PD model system to determine time-kill curves of drugs against MycobacteriaNageshwar R Budha, Robin B Lee, Julian G Hurdle, et al.
Journal of Pharmaceutical and Biomedical Analysis|September 25, 2012
Simple and sensitive assay for quantification of oseltamivir and its active metabolite oseltamivir carboxylate in human plasma using high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry: improved applicability to pharmacokinetic studyZhe-Yi Hu, S Casey Laizure, Bernd Meibohm, et al.
Antimicrobial Agents and Chemotherapy|December 23, 2025
<i>In vitro</i> PK/PD modeling and simulation to accurately assess the antimicrobial activity of tigecycline against <i>Mycobacterium abscessus</i>Hyunseo Park, Sara E Maloney Norcross, Anthony J Hickey, et al.
Journal of Clinical Pharmacology|June 29, 2021
Pediatric Dose Selection for Therapeutic ProteinsPaul R V Malik, Zaid H Temrikar, Pierre Chelle, et al.
Frontiers in Microbiology|May 14, 2026
Effect of biofilm formation on the antimicrobial activity of tigecycline against <i>Mycobacterium abscessus</i> in the hollow fiber infection modelHyunseo Park, Sara E Maloney Norcross, Anthony J Hickey, et al.
American Journal of Veterinary Research|October 4, 2011
Pharmacokinetics of ponazuril after oral administration to healthy llamas (Lama glama)Maria E Prado, Josiah T Ryman, Melanie J Boileau, et al.
Pageof 18

Showing results (51-60 of 171) with videos related to

Sort By:
Pageof 18
Plos One|February 24, 2017
Alterations in cellular pharmacokinetics and pharmacodynamics of elvitegravir in response to ethanol exposure in HIV-1 infected monocytic (U1) cellsNarasimha M Midde, Namita Sinha, Pradeep B Lukka, et al.
Clinical Pharmacology in Drug Development|February 27, 2026
Single-Dose Pharmacokinetic Assessment of TNX-102 SL (Cyclobenzaprine HCl Sublingual Tablets): Results From Randomized, Open-Label Studies in Healthy VolunteersBruce L Daugherty, Bernd Meibohm, Gregory M Sullivan, et al.
Pharmacology Research & Perspectives|July 22, 2015
Preclinical evaluation of SMM-189, a cannabinoid receptor 2-specific inverse agonistChaela Presley, Ammaar Abidi, Satyendra Suryawanshi, et al.
The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG|October 16, 2024
Impact of Age and Concurrent Antiseizure Medication Use on Lacosamide Dose to Concentration Ratio and Dosing in Pediatric PatientsMegan Woods, Stephanie J Phelps, Michael L Christensen, et al.
Tuberculosis (Edinburgh, Scotland)|September 15, 2009
A simple in vitro PK/PD model system to determine time-kill curves of drugs against MycobacteriaNageshwar R Budha, Robin B Lee, Julian G Hurdle, et al.
Journal of Pharmaceutical and Biomedical Analysis|September 25, 2012
Simple and sensitive assay for quantification of oseltamivir and its active metabolite oseltamivir carboxylate in human plasma using high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry: improved applicability to pharmacokinetic studyZhe-Yi Hu, S Casey Laizure, Bernd Meibohm, et al.
Antimicrobial Agents and Chemotherapy|December 23, 2025
<i>In vitro</i> PK/PD modeling and simulation to accurately assess the antimicrobial activity of tigecycline against <i>Mycobacterium abscessus</i>Hyunseo Park, Sara E Maloney Norcross, Anthony J Hickey, et al.
Journal of Clinical Pharmacology|June 29, 2021
Pediatric Dose Selection for Therapeutic ProteinsPaul R V Malik, Zaid H Temrikar, Pierre Chelle, et al.
Frontiers in Microbiology|May 14, 2026
Effect of biofilm formation on the antimicrobial activity of tigecycline against <i>Mycobacterium abscessus</i> in the hollow fiber infection modelHyunseo Park, Sara E Maloney Norcross, Anthony J Hickey, et al.
American Journal of Veterinary Research|October 4, 2011
Pharmacokinetics of ponazuril after oral administration to healthy llamas (Lama glama)Maria E Prado, Josiah T Ryman, Melanie J Boileau, et al.
Pageof 18